# OnCo record cid-078 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cid-078/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cid-078" ;
  schema:name "CID-078"@en ;
  schema:description "CID-078 is an experimental oral macrocycle from Circle Pharma, in phase 1 trials for advanced solid tumours, small cell lung cancer and triple-negative breast cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/cid-078/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/press-releases/circle-pharma-announces-first-patients-dosed-in-phase-1-clinical-trial-of-first-in-class-oral-cyclin-a-b-rxl-inhibitor-cid-078-for-advanced-solid-tumors>, <https://www.biospace.com/press-releases/circle-pharma-announces-first-patients-dosed-in-phase-1-clinical-trial-of-first-in-class-oral-cyclin-a-b-rxl-inhibitor-cid-078-for-advanced-solid-tumors>, <https://www.biospace.com/press-releases/circle-pharma-receives-fda-orphan-drug-designation-for-cid-078-for-the-treatment-of-small-cell-lung-cancer>, <https://clinicaltrials.gov/search?intr=CID-078> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral macrocycle (macrocyclic peptide)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:companies <https://onco.cc/companies/circle-pharma/> ;
  onco:trials <https://onco.cc/trials/nct06577987/> .